Table of Contents 1 Market Overview 1.1 Indoleamine 2,3 Dioxygenase 1 Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 BMS-986205 1.2.3 Dcellvax 1.2.4 Epacadostat 1.2.5 F-001287 1.2.6 Galanal 1.2.7 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Aolpecia 1.3.3 Cervical Cancer 1.3.4 Gastric Cancer 1.3.5 Glioma 1.3.6 Others 1.4 Overview of Global Indoleamine 2,3 Dioxygenase 1 Market 1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 BirchBioMed Inc 2.1.1 BirchBioMed Inc Details 2.1.2 BirchBioMed Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 BirchBioMed Inc SWOT Analysis 2.1.4 BirchBioMed Inc Product and Services 2.1.5 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 IO Biotech ApS 2.2.1 IO Biotech ApS Details 2.2.2 IO Biotech ApS Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 IO Biotech ApS SWOT Analysis 2.2.4 IO Biotech ApS Product and Services 2.2.5 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 F. Hoffmann-La Roche Ltd 2.3.1 F. Hoffmann-La Roche Ltd Details 2.3.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 F. Hoffmann-La Roche Ltd SWOT Analysis 2.3.4 F. Hoffmann-La Roche Ltd Product and Services 2.3.5 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Bristol-Myers Squibb Company 2.4.1 Bristol-Myers Squibb Company Details 2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Bristol-Myers Squibb Company SWOT Analysis 2.4.4 Bristol-Myers Squibb Company Product and Services 2.4.5 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Incyte Corp 2.5.1 Incyte Corp Details 2.5.2 Incyte Corp Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Incyte Corp SWOT Analysis 2.5.4 Incyte Corp Product and Services 2.5.5 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Ensemble Therapeutics Corp 2.6.1 Ensemble Therapeutics Corp Details 2.6.2 Ensemble Therapeutics Corp Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Ensemble Therapeutics Corp SWOT Analysis 2.6.4 Ensemble Therapeutics Corp Product and Services 2.6.5 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Netherlands Translational Research Center BV 2.7.1 Netherlands Translational Research Center BV Details 2.7.2 Netherlands Translational Research Center BV Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Netherlands Translational Research Center BV SWOT Analysis 2.7.4 Netherlands Translational Research Center BV Product and Services 2.7.5 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 Globavir Biosciences Inc 2.8.1 Globavir Biosciences Inc Details 2.8.2 Globavir Biosciences Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Globavir Biosciences Inc SWOT Analysis 2.8.4 Globavir Biosciences Inc Product and Services 2.8.5 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.9 Genentech Inc 2.9.1 Genentech Inc Details 2.9.2 Genentech Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Genentech Inc SWOT Analysis 2.9.4 Genentech Inc Product and Services 2.9.5 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.10 Kyowa Hakko Kirin 2.10.1 Kyowa Hakko Kirin Details 2.10.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Kyowa Hakko Kirin SWOT Analysis 2.10.4 Kyowa Hakko Kirin Product and Services 2.10.5 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.11 NewLink Genetics Corp 2.11.1 NewLink Genetics Corp Details 2.11.2 NewLink Genetics Corp Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 NewLink Genetics Corp SWOT Analysis 2.11.4 NewLink Genetics Corp Product and Services 2.11.5 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.12 Regen BioPharma Inc 2.12.1 Regen BioPharma Inc Details 2.12.2 Regen BioPharma Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Regen BioPharma Inc SWOT Analysis 2.12.4 Regen BioPharma Inc Product and Services 2.12.5 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.13 Pfizer Inc 2.13.1 Pfizer Inc Details 2.13.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 Pfizer Inc SWOT Analysis 2.13.4 Pfizer Inc Product and Services 2.13.5 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.14 Redx Pharma Plc 2.14.1 Redx Pharma Plc Details 2.14.2 Redx Pharma Plc Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Redx Pharma Plc SWOT Analysis 2.14.4 Redx Pharma Plc Product and Services 2.14.5 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Indoleamine 2,3 Dioxygenase 1 Manufacturer Market Share in 2019 3.3.2 Top 6 Indoleamine 2,3 Dioxygenase 1 Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Regions 4.1.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Regions (2015-2020) 4.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Regions (2015-2020) 4.2 North America Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 4.3 Europe Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 4.5 South America Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Country 5.1.1 North America Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Country (2015-2020) 5.1.2 North America Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Country (2015-2020) 5.2 United States Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 5.3 Canada Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 5.4 Mexico Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Country 6.1.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Country (2015-2020) 6.1.2 Europe Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Country (2015-2020) 6.2 Germany Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 6.3 UK Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 6.4 France Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 6.5 Russia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 6.6 Italy Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Regions (2015-2020) 7.2 China Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7.3 Japan Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7.4 Korea Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7.5 India Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 7.7 Australia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Country 8.1.1 South America Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Country (2015-2020) 8.1.2 South America Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Country (2015-2020) 8.2 Brazil Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 8.3 Argentina Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 9.3 Turkey Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 9.4 Egypt Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 9.5 South Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Indoleamine 2,3 Dioxygenase 1 Sales and Market Share by Type (2015-2020) 10.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Type (2015-2020) 10.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2015-2020) 11 Global Indoleamine 2,3 Dioxygenase 1 Market Segment by Application 11.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2015-2020) 11.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2015-2020) 11.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2015-2020) 12 Market Forecast 12.1 Global Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Growth Rate (2021-2025) 12.2 Indoleamine 2,3 Dioxygenase 1 Market Forecast by Regions (2021-2025) 12.2.1 North America Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) 12.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) 12.2.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) 12.2.4 South America Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) 12.2.5 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) 12.3 Indoleamine 2,3 Dioxygenase 1 Market Forecast by Type (2021-2025) 12.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Type (2021-2025) 12.3.2 Global Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Type (2021-2025) 12.4 Indoleamine 2,3 Dioxygenase 1 Market Forecast by Application (2021-2025) 12.4.1 Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Application (2021-2025) 12.4.2 Global Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Indoleamine 2,3 Dioxygenase 1 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Indoleamine 2,3 Dioxygenase 1 by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Indoleamine 2,3 Dioxygenase 1 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. BirchBioMed Inc Basic Information, Manufacturing Base and Competitors Table 8. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Major Business Table 9. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 10. BirchBioMed Inc SWOT Analysis Table 11. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 12. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. IO Biotech ApS Basic Information, Manufacturing Base and Competitors Table 14. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Major Business Table 15. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 16. IO Biotech ApS SWOT Analysis Table 17. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product and Services Table 18. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors Table 20. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Major Business Table 21. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 22. F. Hoffmann-La Roche Ltd SWOT Analysis Table 23. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product and Services Table 24. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table 26. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Major Business Table 27. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 28. Bristol-Myers Squibb Company SWOT Analysis Table 29. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product and Services Table 30. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Incyte Corp Basic Information, Manufacturing Base and Competitors Table 32. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Major Business Table 33. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 34. Incyte Corp SWOT Analysis Table 35. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product and Services Table 36. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Ensemble Therapeutics Corp Basic Information, Manufacturing Base and Competitors Table 38. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Major Business Table 39. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 40. Ensemble Therapeutics Corp SWOT Analysis Table 41. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services Table 42. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Netherlands Translational Research Center BV Basic Information, Manufacturing Base and Competitors Table 44. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Major Business Table 45. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 46. Netherlands Translational Research Center BV SWOT Analysis Table 47. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product and Services Table 48. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. Globavir Biosciences Inc Basic Information, Manufacturing Base and Competitors Table 50. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Major Business Table 51. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 52. Globavir Biosciences Inc SWOT Analysis Table 53. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 54. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 55. Genentech Inc Basic Information, Manufacturing Base and Competitors Table 56. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Major Business Table 57. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 58. Genentech Inc SWOT Analysis Table 59. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 60. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 61. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors Table 62. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Major Business Table 63. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 64. Kyowa Hakko Kirin SWOT Analysis Table 65. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product and Services Table 66. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 67. NewLink Genetics Corp Basic Information, Manufacturing Base and Competitors Table 68. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Major Business Table 69. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 70. NewLink Genetics Corp SWOT Analysis Table 71. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services Table 72. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 73. Regen BioPharma Inc Basic Information, Manufacturing Base and Competitors Table 74. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Major Business Table 75. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 76. Regen BioPharma Inc SWOT Analysis Table 77. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 78. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors Table 80. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Major Business Table 81. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 82. Pfizer Inc SWOT Analysis Table 83. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 84. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 85. Redx Pharma Plc Basic Information, Manufacturing Base and Competitors Table 86. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Major Business Table 87. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Total Revenue (USD Million) (2017-2018) Table 88. Redx Pharma Plc SWOT Analysis Table 89. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product and Services Table 90. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 91. Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturer (2018-2019) (K Pcs) Table 92. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturer (2018-2019) (USD Million) Table 93. Global Indoleamine 2,3 Dioxygenase 1 Sales by Regions (2015-2020) (K Pcs) Table 94. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Regions (2015-2020) Table 95. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Regions (2015-2020) (USD Million) Table 96. North America Indoleamine 2,3 Dioxygenase 1 Sales by Countries (2015-2020) (K Pcs) Table 97. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries (2015-2020) Table 98. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Countries (2015-2020) (USD Million) Table 99. North America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) Table 100. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Countries (2015-2020) (K Pcs) Table 101. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries (2015-2020) Table 102. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Countries (2015-2020) (USD Million) Table 103. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Regions (2015-2020) (K Pcs) Table 104. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Regions (2015-2020) Table 105. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue by Regions (2015-2020) (USD Million) Table 106. South America Indoleamine 2,3 Dioxygenase 1 Sales by Countries (2015-2020) (K Pcs) Table 107. South America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries (2015-2020) Table 108. South America Indoleamine 2,3 Dioxygenase 1 Revenue by Countries (2015-2020) (USD Million) Table 109. South America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) Table 110. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Countries (2015-2020) (K Pcs) Table 111. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries (2015-2020) Table 112. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue by Countries (2015-2020) (USD Million) Table 113. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) Table 114. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2015-2020) (K Pcs) Table 115. Global Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2015-2020) Table 116. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2015-2020) (USD Million) Table 117. Global Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2015-2020) Table 118. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2015-2020) (K Pcs) Table 119. Global Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2015-2020) Table 120. Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Regions (2021-2025) (K Pcs) Table 121. Global Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Regions (2021-2025) Table 122. Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Type (2021-2025) (K Pcs) Table 123. Global Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Type (2021-2025) Table 124. Global Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Application (2021-2025) Table 125. Global Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Application (2021-2025) Table 126. Direct Channel Pros & Cons Table 127. Indirect Channel Pros & Cons Table 128. Distributors/Traders/ Dealers List List of Figures Figure 1. Indoleamine 2,3 Dioxygenase 1 Picture Figure 2. Global Sales Market Share of Indoleamine 2,3 Dioxygenase 1 by Type in 2019 Figure 3. BMS-986205 Picture Figure 4. Dcellvax Picture Figure 5. Epacadostat Picture Figure 6. F-001287 Picture Figure 7. Galanal Picture Figure 8. Others Picture Figure 9. Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application in 2018 Figure 10. Aolpecia Picture Figure 11. Cervical Cancer Picture Figure 12. Gastric Cancer Picture Figure 13. Glioma Picture Figure 14. Others Picture Figure 15. Global Indoleamine 2,3 Dioxygenase 1 Market Status and Outlook (2015-2025) (USD Million) Figure 16. United States Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 17. Canada Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 18. Mexico Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 19. Germany Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 20. France Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 21. UK Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 22. Russia Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 23. Italy Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 24. China Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 25. Japan Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 26. Korea Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 27. India Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 28. Southeast Asia Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 29. Australia Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 30. Brazil Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 31. Egypt Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 32. Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 33. South Africa Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 34. Turkey Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Growth Rate (2015-2025) Figure 35. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Manufacturer in 2019 Figure 36. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Manufacturer in 2019 Figure 37. Top 3 Indoleamine 2,3 Dioxygenase 1 Manufacturer (Revenue) Market Share in 2019 Figure 38. Top 6 Indoleamine 2,3 Dioxygenase 1 Manufacturer (Revenue) Market Share in 2019 Figure 39. Key Manufacturer Market Share Trend Figure 40. Global Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 41. Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 42. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Regions (2015-2020) Figure 43. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Regions in 2018 Figure 44. North America Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) Figure 45. Europe Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) Figure 46. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) Figure 47. South America Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) Figure 48. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) Figure 49. North America Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 50. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries (2015-2020) Figure 51. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries in 2018 Figure 52. North America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) (USD Million) Figure 53. North America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries in 2018 Figure 54. United States Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 55. Canada Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 56. Mexico Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 57. Europe Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 58. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) Figure 59. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries in 2019 Figure 60. Germany Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 61. UK Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 62. France Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 63. Russia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 64. Italy Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 65. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 66. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Regions 2019 Figure 67. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Regions 2019 Figure 68. China Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 69. Japan Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 70. Korea Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 71. India Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 72. Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 73. South America Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 74. South America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries in 2019 Figure 75. South America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries in 2019 Figure 76. Brazil Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 77. Argentina Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 78. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2015-2020) (USD Million) Figure 79. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Countries in 2019 Figure 80. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries (2015-2020) Figure 81. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Countries in 2019 Figure 82. Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 83. Egypt Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 84. Turkey Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 85. South Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2015-2020) (K Pcs) Figure 86. Global Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2025) (K Pcs) Figure 87. Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2021-2025) (USD Million) Figure 88. North America Sales Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) (K Pcs) Figure 89. Europe Sales Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) (K Pcs) Figure 90. Asia-Pacific Sales Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) (K Pcs) Figure 91. South America Sales Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) (K Pcs) Figure 92. Middle East & Africa Sales Indoleamine 2,3 Dioxygenase 1 Market Forecast (2021-2025) (K Pcs) Figure 93. Sales Channel: Direct Channel vs Indirect Channel

BirchBioMed Inc IO Biotech ApS F. Hoffmann-La Roche Ltd Bristol-Myers Squibb Company Incyte Corp Ensemble Therapeutics Corp Netherlands Translational Research Center BV Globavir Biosciences Inc Genentech Inc Kyowa Hakko Kirin NewLink Genetics Corp Regen BioPharma Inc Pfizer Inc Redx Pharma Plc